CVE-2020-14486

CVE-2020-14486 is a medium-severity vulnerability in Openclinic Ga Project Openclinic Ga with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-863.

Key facts

Description

An attacker may bypass permission/authorization checks in OpenClinic GA 5.09.02 and 5.89.05b by ignoring the redirect of a permission failure, which may allow unauthorized execution of commands.

Frequently asked questions

What is CVE-2020-14486?
An attacker may bypass permission/authorization checks in OpenClinic GA 5.09.02 and 5.89.05b by ignoring the redirect of a permission failure, which may allow unauthorized execution of commands.
How severe is CVE-2020-14486?
CVE-2020-14486 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2020-14486 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (67th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-14486?
CVE-2020-14486 primarily affects Openclinic Ga Project Openclinic Ga. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-14486?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-14486 published?
CVE-2020-14486 was published on 2020-07-29 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Openclinic Ga Project Openclinic Ga

All CVEs affecting Openclinic Ga Project Openclinic Ga →

Other CWE-863 (Incorrect Authorization) vulnerabilities

Browse all CWE-863 (Incorrect Authorization) vulnerabilities →